Dokkyo Medical Journal
Online ISSN : 2436-522X
Print ISSN : 2436-5211

この記事には本公開記事があります。本公開記事を参照してください。
引用する場合も本公開記事を引用してください。

Changes and Possible Risk Factors in the Prevalence of Allergic Rhinitis among Children in Ulaanbaatar, Mongolia from 2009 to 2021
Clyde Fumiaki ItoMotoko NakayamaAgiimaa DondogSolongo BandiSonomjamts MunkhbayarlakhShigemi Yoshihara
著者情報
ジャーナル オープンアクセス 早期公開

論文ID: 2023-057

この記事には本公開記事があります。
詳細
抄録

Background: The WHO Collaborating Center at Dokkyo Medical University conducted a survey in Ulaanbaatar in 2009 on the prevalence of pediatric asthma and allergic rhinitis (AR). We report on a follow-up survey done in 2021 to measure changes since 2009 and identify risk factors.

Methods: Questionnaire based on International Study of Asthma and Allergies in Childhood with modifications was used in 2009 and 2021. The parent (s) of 200 boys and 200 girls, 6-7 years old, were randomly selected from and interviewed at the 10 clinic areas used in 2009. 50% were city districts and 50% were urban districts. Statistical data was analyzed using odds ratios analysis and chi-square testing.

Results: Comparing 2009 and 2021, prevalence of AR decreased by 13.6%. In houses where there was exposure to tobacco smoke, AR decreased by 21.3% from 64.0% to 42.7%. In children with asthma, AR decreased by 9.8% from 25.8% to 16.0%. In children with respiratory infection when <1 year old, AR decreased by 7.9% from 41.8% to 33.9%.

Conclusion: In comparing 2009 and 2021, the significance was greater between children with than without AR, with P < 0.001 for those exposed to tobacco smoke, and P < 0.005 for those with asthma. There was no significance for children with a history of respiratory infection when <1 year old. There was significance of exposure to tobacco smoke and having asthma as risk factors for AR but not for children with a history of respiratory infection when <1 year old.

著者関連情報
© 2024 Dokkyo Medical Society

This article is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License (https://creativecommons.org/licenses/by-nc-nd/4.0/).
https://creativecommons.org/licenses/by-nc-nd/4.0/
feedback
Top